Jan 16, 2020 / 06:30PM GMT
Scott Kramer;JPMorgan;Investment Banking Associate -
Good morning. My name is Scott Kramer. I'm with the JPMorgan Health Care Investment Banking team. It's my pleasure to introduce to you our next presenter, Al Altomari, Chairman and CEO of Agile Therapeutics.
Alfred F. Altomari - Agile Therapeutics, Inc. - Chairman & CEO
Great. Got it. Thank you, everybody. So on behalf of Agile Therapeutics, we'd like to thank Michael Gaito and the banking team for this invitation and also the conference organizers for all their hospitality. So I'm thrilled to be giving you an update on Agile Therapeutics. This is an important year, as you'll hear in my presentation, for the company. So I hope for those of you who are still designing your portfolios and consider portfolio investments, I hope you'll consider Agile Therapeutics as one of your investments this year.
Before I begin, Agile Therapeutics is a publicly traded company. So throughout my presentation, I will be making forward-looking statements, so I would encourage you to take a
Agile Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Jan 17, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers